| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Congress Calendar
|
|
|
|
82 |
1 |
p. e22-e24
|
artikel
|
| 2 |
Contents
|
|
|
|
82 |
1 |
p. ix
|
artikel
|
| 3 |
Contents
|
|
|
|
82 |
1 |
p. x
|
artikel
|
| 4 |
Contents
|
|
|
|
82 |
1 |
p. iv
|
artikel
|
| 5 |
Contents
|
|
|
|
82 |
1 |
p. viii
|
artikel
|
| 6 |
Contents
|
|
|
|
82 |
1 |
p. vi
|
artikel
|
| 7 |
Corrigendum to “Cost-Effectiveness of the Stockholm3 Test and Magnetic Resonance Imaging in Prostate Cancer Screening: A Microsimulation Study” [Eur Urol 2022]
|
Hao, Shuang
|
|
|
82 |
1 |
p. e21
|
artikel
|
| 8 |
Corrigendum to “Intracorporeal Versus Extracorporeal Robot-assisted Kidney Autotransplantation: Experience of the ERUS RAKT Working Group” [Eur Urol 2022;81(2):168–75]
|
Breda, Alberto
|
|
|
82 |
1 |
p. e20
|
artikel
|
| 9 |
Corrigendum to “What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021” [Eur Urol 82(1):6–11]
|
Turco, Fabio
|
|
|
82 |
1 |
p. e18-e19
|
artikel
|
| 10 |
Cost-Effectiveness of the Stockholm3 Test and Magnetic Resonance Imaging in Prostate Cancer Screening: A Microsimulation Study
|
Hao, Shuang
|
|
|
82 |
1 |
p. 12-19
|
artikel
|
| 11 |
Editorial Board
|
|
|
|
82 |
1 |
p. i-ii
|
artikel
|
| 12 |
European Association of Urology Guidelines on the Diagnosis and Management of Female Non-neurogenic Lower Urinary Tract Symptoms. Part 1: Diagnostics, Overactive Bladder, Stress Urinary Incontinence, and Mixed Urinary Incontinence
|
Nambiar, Arjun K.
|
|
|
82 |
1 |
p. 49-59
|
artikel
|
| 13 |
European Association of Urology Guidelines on the Management of Female Non-neurogenic Lower Urinary Tract Symptoms. Part 2: Underactive Bladder, Bladder Outlet Obstruction, and Nocturia
|
Arlandis, Salvador
|
|
|
82 |
1 |
p. 60-70
|
artikel
|
| 14 |
High-dose Radiotherapy or Androgen Deprivation Therapy (HEAT) as Treatment Intensification for Localized Prostate Cancer: An Individual Patient–data Network Meta-analysis from the MARCAP Consortium
|
Kishan, Amar U.
|
|
|
82 |
1 |
p. 106-114
|
artikel
|
| 15 |
Improved Harm/Benefit Ratio and Cost-effectiveness of Prostate Cancer Screening Using New Technologies
|
Heijnsdijk, Eveline A.M.
|
|
|
82 |
1 |
p. 20-21
|
artikel
|
| 16 |
Intensification of Systemic Therapy in Addition to Definitive Local Treatment in Nonmetastatic Unfavourable Prostate Cancer: A Systematic Review and Meta-analysis
|
Rajwa, Pawel
|
|
|
82 |
1 |
p. 82-96
|
artikel
|
| 17 |
International Bladder Cancer Group Consensus Statement on Clinical Trial Design for Patients with Bacillus Calmette-Guérin–exposed High-risk Non–muscle-invasive Bladder Cancer
|
Roumiguié, Mathieu
|
|
|
82 |
1 |
p. 34-46
|
artikel
|
| 18 |
Is It PRIME Time for Biparametric Magnetic Resonance Imaging in Prostate Cancer Diagnosis?
|
Ng, Alexander
|
|
|
82 |
1 |
p. 1-2
|
artikel
|
| 19 |
Key Notes on Pembrolizumab and Docetaxel Combination Therapy for Metastatic Castration-Resistant Prostate Cancer
|
Thoman, Maxton E.
|
|
|
82 |
1 |
p. 31-33
|
artikel
|
| 20 |
Management of Patients with Advanced Prostate Cancer: Report from the Advanced Prostate Cancer Consensus Conference 2021
|
Gillessen, Silke
|
|
|
82 |
1 |
p. 115-141
|
artikel
|
| 21 |
Newly Released Guidelines on Female Non-neurogenic Lower Urinary Tract Symptoms: Resuscitating Female Urology
|
Cornu, Jean-Nicolas
|
|
|
82 |
1 |
p. 71-72
|
artikel
|
| 22 |
Optimizing Clinical Trial Design for Patients with Non–muscle-invasive Bladder Cancer
|
Weinstock, Chana
|
|
|
82 |
1 |
p. 47-48
|
artikel
|
| 23 |
Pembrolizumab Plus Docetaxel and Prednisone in Patients with Metastatic Castration-resistant Prostate Cancer: Long-term Results from the Phase 1b/2 KEYNOTE-365 Cohort B Study
|
Yu, Evan Y.
|
|
|
82 |
1 |
p. 22-30
|
artikel
|
| 24 |
Re: Darolutamide and Survival in Metastatic, Hormone-sensitive Prostate Cancer
|
Chen, Kenneth
|
|
|
82 |
1 |
p. 146-147
|
artikel
|
| 25 |
Re: Fabio Turco, Andrew Armstrong, Gerhardt Attard, et al. What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021. Eur Urol. 2022;82:6–11
|
Wei, Yu
|
|
|
82 |
1 |
p. e14
|
artikel
|
| 26 |
Re: Fertility Potential Is Compromised in 20% to 25% of Boys with Nonsyndromic Cryptorchidism Despite Orchidopexy Within the First Year of Life
|
Radmayr, Christian
|
|
|
82 |
1 |
p. 143
|
artikel
|
| 27 |
Re: Matthew R. Smith, Maha Hussain, Fred Saad, et al. Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer. N Engl J Med. 2022;386:1132–1142
|
Di Lorenzo, Giuseppe
|
|
|
82 |
1 |
p. e17
|
artikel
|
| 28 |
Re: Oncological Benefit of Re-resection for T1 Bladder Cancer: A Comparative Effectiveness Study
|
Alfred Witjes, J.
|
|
|
82 |
1 |
p. 142
|
artikel
|
| 29 |
Re: Performance of a Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography–derived Risk-stratification Tool for High-risk and Very High-risk Prostate Cancer
|
Bjartell, Anders
|
|
|
82 |
1 |
p. 145-146
|
artikel
|
| 30 |
Reply to Benjamin Davies, Keith Kowalczyk RE: Zachary Klaassen, Emily Vertosick, Andrew J. Vickers, et al. Optimal Dissemination of Scientific Manuscripts via Social Media: A Prospective Trial Comparing Visual Abstracts Versus Key Figures in Consecutive Original Manuscripts. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.01.041
|
Klaassen, Zachary
|
|
|
82 |
1 |
p. e12
|
artikel
|
| 31 |
Reply to Yu Wei, Yao Zhu, and Dingwei Ye's Letter to the Editor re: Fabio Turco, Andrew Armstrong, Gerhardt Attard, et al. What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021. Eur Urol. 2022;82:6–11
|
Turco, F.
|
|
|
82 |
1 |
p. e13
|
artikel
|
| 32 |
Re: Survival After Radical Prostatectomy Versus Radiation Therapy in High-risk and Very High-risk Prostate Cancer
|
Pushkar, Dmitry
|
|
|
82 |
1 |
p. 144-145
|
artikel
|
| 33 |
Re: Targeted Prostate Biopsy: Umbra, Penumbra, and Value of Perilesional Sampling
|
Padhani, Anwar R.
|
|
|
82 |
1 |
p. 143-144
|
artikel
|
| 34 |
Re: Valentin H. Meissner, Isabel Rauscher, Kristina Schwamborn, et al. Radical Prostatectomy Without Prior Biopsy Following Multiparametric Magnetic Resonance Imaging and Prostate-specific Membrane Antigen Positron Emission Tomography. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.11.019
|
Samaratunga, Hemamali
|
|
|
82 |
1 |
p. e15-e16
|
artikel
|
| 35 |
Re: Zachary Klaassen, Emily Vertosick, Andrew J. Vickers, et al. Optimal Dissemination of Scientific Manuscripts via Social Media: A Prospective Trial Comparing Visual Abstracts Versus Key Figures in Consecutive Original Manuscripts. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.01.041
|
Davies, Benjamin
|
|
|
82 |
1 |
p. e11
|
artikel
|
| 36 |
Robot-assisted Prostate-specific Membrane Antigen–radioguided Salvage Surgery in Recurrent Prostate Cancer Using a DROP-IN Gamma Probe: The First Prospective Feasibility Study
|
de Barros, Hilda A.
|
|
|
82 |
1 |
p. 97-105
|
artikel
|
| 37 |
The Platinum Hall of Fame
|
|
|
|
82 |
1 |
p. e1-e10
|
artikel
|
| 38 |
Thulium Fiber Laser: A Leap Towards Stone-free Status?
|
Raskolnikov, Dima
|
|
|
82 |
1 |
p. 80-81
|
artikel
|
| 39 |
Thulium Fibre Laser versus Holmium:YAG for Ureteroscopic Lithotripsy: Outcomes from a Prospective Randomised Clinical Trial
|
Ulvik, Øyvind
|
|
|
82 |
1 |
p. 73-79
|
artikel
|
| 40 |
Transperineal Prostate Biopsy Is the New Black: What Are the Next Targets?
|
Lenfant, Louis
|
|
|
82 |
1 |
p. 3-5
|
artikel
|
| 41 |
What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021
|
Turco, Fabio
|
|
|
82 |
1 |
p. 6-11
|
artikel
|
Tijdschrift beschrijving